Eisler Capital (US)’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$24.8M Sell
239,100
-107,700
-31% -$11M 0.53% 43
2024
Q2
$33.7M Buy
346,800
+43,000
+14% +$3.97M 0.6% 33
2024
Q1
$27.4M Sell
303,800
-61,600
-17% -$5.22M 0.68% 20
2023
Q4
$29.1M Buy
365,400
+207,700
+132% +$15.6M 0.92% 15
2023
Q3
$11.2M Buy
157,700
+108,400
+220% +$8.1M 0.29% 72
2023
Q2
$3.8M Buy
+49,300
New +$3.82M 0.13% 132

Other funds holding CL

Eisler Capital (US)'s CL Position: Q3 2024 in Review

Eisler Capital (US) reduced its Colgate-Palmolive (CL) stake by 31% in Q3 2024, selling an estimated $364K and leaving 7,805 shares worth $810K. The position accounts for 0.02% of the portfolio, ranked #399.

Eisler Capital (US) first reported a position in CL in Q2 2023 and has held it in 5 quarters since. The position peaked at $5.7M in Q3 2023. 1,910 funds tracked by Wall St. Rank hold CL as of Q3 2024.

  • Eisler Capital (US) held 7,805 shares of Colgate-Palmolive worth $810K as of Q3 2024.
  • Eisler Capital (US) sold 3,570 Colgate-Palmolive shares in Q3 2024, an estimated $364K.
  • Colgate-Palmolive made up 0.02% of Eisler Capital (US)'s portfolio in Q3 2024, its #399 holding.
  • Eisler Capital (US) first reported a position in Colgate-Palmolive in Q2 2023 and has held it in 5 quarters since.
  • Eisler Capital (US)'s Colgate-Palmolive position peaked at $5.7M in Q3 2023.
  • 1,910 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2024.

Based on Eisler Capital (US)'s 13F filing for Q3 2024, filed 14 Nov 2024.